Biotechhealthcare News

The latest biotechhealthcare stories, summarized by AI

CARGO Therapeutics Raises $281M in IPO and Rings Opening Bell

Biotech company CARGO Therapeutics is set to raise approximately $281 million through its initial public offering (IPO) on the Nasdaq, selling 18.75 million shares at $15 each. This IPO is considered one of the largest in the industry this year, as the biotech IPO market has been relatively slow in 2022.

2 years ago•Source: Endpoints News

Aiolos Bio secures $245M Series A to develop breakthrough asthma treatment

biotechhealthcare

0.72 min•2 years ago

Aiolos Bio secures $245M Series A to develop breakthrough asthma treatment

Aiolos Bio, founded by former Genentech executives, has raised $245 million in a Series A funding round to advance an asthma drug licensed from China. The startup plans to initiate a Phase II asthma study next year for its anti-TSLP antibody, which is its sole drug candidate. Aiolos Bio's CEO, Khurem Farooq, previously led Gyroscope Therapeutics, which was acquired by Novartis in December 2021.

via Endpoints News